Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 57,994 | 43,103 | 30,434 | 26,117 | 16,479 |
| Gross Profit | 57,994 | 43,103 | 30,434 | 26,117 | 16,479 |
| Operating Expenses | 194,577 | 149,471 | 121,304 | 95,672 | 48,638 |
| Operating Income | -136,583 | -106,368 | -90,870 | -69,555 | -32,159 |
| Other Income | 2,352 | 6,835 | 5,527 | 2,012 | 525 |
| Pre-tax Income | -134,231 | -99,533 | -85,343 | -67,543 | -31,634 |
| Net Income Continuous | -134,231 | -99,533 | -85,343 | -67,543 | -31,634 |
| Net Income | $-134,231 | $-99,533 | $-85,343 | $-67,543 | $-31,634 |
| EPS Basic Total Ops | -2.40 | -2.11 | -1.98 | -1.88 | -1.42 |
| EPS Basic Continuous Ops | -2.40 | -2.11 | -1.98 | -1.88 | -1.42 |
| EPS Diluted Total Ops | -2.40 | -2.11 | -1.98 | -1.88 | -1.42 |
| EPS Diluted Continuous Ops | -2.40 | -2.11 | -1.98 | -1.88 | -1.42 |
| EPS Diluted Before Non-Recurring Items | -2.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-130,272 | $-100,781 | $-86,406 | $-66,561 | $-31,055 |